窪田製薬ホールディングス株式会社
US dollar amounts use ¥158.0 per dollar.
| Fiscal year | Revenue | Net income | Total assets | Net assets | Equity ratio | Source |
|---|---|---|---|---|---|---|
| Dec 2025 | ¥21.3M | −¥676M | ¥2.0B | ¥1.8B | 91.6% | EDINET (consol.) |
| Dec 2024 | ¥27.2M | −¥1.3B | ¥1.5B | ¥1.4B | 90.1% | EDINET (consol.) |
| Dec 2023 | ¥39.9M | −¥1.5B | ¥3.0B | ¥2.6B | 87.7% | EDINET (consol.) |
| Dec 2022 | ¥8.3M | −¥2.0B | ¥4.4B | ¥3.9B | 89.4% | EDINET (consol.) |
| Dec 2021 | — | −¥2.6B | ¥4.8B | ¥4.2B | 85.9% | EDINET (consol.) |
From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）
See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.